Eprosartan Mesylate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Eprosartan Mesylate drug offered from Mylan Pharmaceuticals Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | eprosartan mesylate |
SUBSTANCE NAME: | EPROSARTAN MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-20 |
END MARKETING DATE: | 0000-00-00 |
Eprosartan Mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | Eprosartan Mesylate from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600(mg/1) |
START MARKETING DATE: | 2011-12-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-6629_e7c67baa-202a-416c-8938-43f542027c56 |
PRODUCT NDC: | 0378-6629 |
APPLICATION NUMBER: | ANDA202012 |
Other EPROSARTAN MESYLATE Pharmaceutical Manufacturers / Labelers: